Table 1.
Treatment Group | N | Weight, kg | LVEDP, cmH2O | Cardiac Output, ml·min−1·kg−1 | Aortic Pressure, cmH2O | pH | Pao2, Torr | Paco2, Torr |
---|---|---|---|---|---|---|---|---|
Controls(normoxic) | 10 | 3.65 ± 0.23 | 4.3 ± 0.4 | 383 ± 26 | 82 ± 3 | 7.33 ± 0.02 | 91 ± 3 | 35 ± 1 |
Chronic hypoxic | 8 | 2.5 ± 0.16* | 5.3 ± 0.3 | 349 ± 18 | 77 ± 3 | 7.39 ± 0.02 | 93 ± 8 | 34 ± 1 |
Low-dose BH4-treated chronic hypoxic | 4 | 2.61 ± 0.16* | 5.3 ± 1 | 305 ± 12 | 78 ± 6 | 7.36 ± 0.01 | 89 ± 3 | 34 ± 2 |
High-dose BH4-treated chronic hypoxic | 12 | 2.65 ± 0.09* | 4.8 ± 0.3 | 428 ± 15*+! | 76 ± 2 | 7.35 ± 0.01 | 95 ± 4 | 34 ± 1 |
Values are means ± SE; N, no. of animals.
LVEDP, left ventricular end-diastolic pressure; Pao2, arterial Po2; Paco2, arterial Pco2. Different from
normoxic controls,
chronic hypoxia, and
low-dose oral BH4 (sapropterin dihydrochloride)-treated chronic hypoxic (P < 0.05; ANOVA with post hoc comparison test).